Mechanistically, our results uncover that Rab26 regulates the autophagic degradation of phosphorylated Src to inhibit the invasion and migration of breast cancer cells, indicating that Rab26 is a novel tumor suppressor for breast cancer. Here, SRC is linked to breast carcinoma.